These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 810673)

  • 1. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC; Bräuninger HJ
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1483-6. PubMed ID: 810673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M; Cuppone R; Ricci GL
    Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M; Vizzini GB
    Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
    Kirsch R
    Schweiz Rundsch Med Prax; 1975 Nov; 64(44):1414-7. PubMed ID: 1236699
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
    Sarti F; Milandri GL; Piemontese A; Macchia S; Simoni S; Dal Monte PR
    Minerva Dietol Gastroenterol; 1984; 30(3):273-80. PubMed ID: 6504377
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperaldosteronism in the acute phase of myocardial infarction. Effects of its treatment on the prevention of ventricular fibrillation].
    Denis B; Dimitriou R; Machecourt J; Wolf JE; Page E; Reboud JP
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():35-40. PubMed ID: 6428361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of diuretics in preventing ascites recurrence.
    Arrigoni A; Andriulli A; Gindro T; Verme G
    Br J Clin Pract; 1988 Mar; 42(3):116-20. PubMed ID: 3207572
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F; Remonda G; Morachioli N; Pugnani M
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic experience with osyrol 100/Lasix in the treatment of congestive heart failure (author's transl)].
    Freude J
    MMW Munch Med Wochenschr; 1979 Jun; 121(24):827-30. PubMed ID: 111084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
    Tartagni F; Ambrosioni E
    Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
    Russo R; Schena FP; Colombo Pirola L
    Clin Ter; 1984 Apr; 109(1):23-9. PubMed ID: 6233076
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M; Radaeli E; Ciaccio S; Corsini R; Trebbi R
    Clin Ter; 1976 Feb; 76(3):215-34. PubMed ID: 963962
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aldosterone antagonists in coronary insufficiency].
    Osswald H
    Med Klin; 1978 Jan; 73(3):84-8. PubMed ID: 622061
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
    Tartagni F; Pasetti L; Ambrosioni E; Magnani B
    G Clin Med; 1979 Mar; 60(3):196-206. PubMed ID: 520727
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of Soludactone in cardiac surgery in adults].
    Fogliani J; Capuccio P; Goudard A; Guillen JC; Monties JR
    Ann Anesthesiol Fr; 1975; 16(3):189-96. PubMed ID: 241276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hyperaldosteronism].
    Jacobelli A
    Clin Ter; 1984 Jun; 109(6):575-81. PubMed ID: 6236949
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrocardiographic observations in secondary aldosteronism].
    Hilmer W
    Med Klin; 1972 Jan; 67(4):128-33. PubMed ID: 5060139
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
    Haschke F; Wimmer M; Parth K
    Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.